Clinical Trial Update: A Study to Investigate How Safe and Well Tolerated RV568 is in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 study evaluating the safety and tolerability of RV568 in patients with chronic obstructive pulmon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• RV568

Snippet

Sponsor: Respivert Ltd | Conditions: Chronic Obstructive Pulmonary Disease | Phase 2 | Status: COMPLETED